New lab and regulatory health developments

What's happened

This week has seen several medical research and regulatory developments. Insilico Medicine has reported that its experimental drug rentosertib changed blood‑protein patterns that aging clocks read as three to four years younger in a small trial. Stanford teams have published studies showing they can grow hindbrain neurons separately and implant human cortical organoids into mice. The US health department has appointed permanent directors for three FDA centers.

What's behind the headline?

What the reports show

• Insilico Medicine has reported a small trial where rentosertib changed blood‑protein signatures so that several ageing clocks estimated patients to be three to four years younger. The trial analysed 42 patients with idiopathic pulmonary fibrosis over 12 weeks and produced preliminary biomarker changes but not proof of longer life.

• Stanford researchers have published work that separates hindbrain progenitors from forebrain/midbrain progenitors and that implants human cortical organoids into mice lacking much of their cortex; the organoids established connections and tissue growth in host animals.

• The US Department of Health and Human Services has named permanent directors for three major FDA centres, moving acting leaders into full roles for drugs, vaccines and tobacco products and creating a new technology oversight post.

Why this matters now

• The rentosertib findings will shift attention and funding toward drugs flagged by AI platforms; investors and researchers will push for larger trials to test whether short‑term biomarker shifts translate into clinical benefit. This will increase pressure on Insilico and partners to move into larger, placebo‑controlled studies.

• The Stanford organoid and developmental studies will change how neuroscientists model human brain development and disease. Researchers will prioritise experiments that use the xenocortical mice to study disorders tied to hindbrain neurons and cortical development, which will accelerate disease modelling but raise ethical and regulatory questions about human‑animal neural chimaeras.

• Permanent FDA appointments will stabilise regulatory decision‑making and speed reviews in areas flagged by the agency leadership, including psychedelic therapies and vaccine regulation. This will affect how quickly experimental drugs and biologics move through the US regulatory pipeline.

Risks and likely next steps

• The rentosertib results are exploratory. Small sample size, patient selection (all had lung disease), and short follow‑up mean biomarker shifts will likely fail to predict long‑term clinical benefit until large trials report. Expect rigorous scepticism and calls for independent replication.

• Organoid grafting in mice will prompt regulatory scrutiny and ethical debate. Labs will pursue targeted disease studies (ALS, SMA, epilepsy), but journals and funders will demand transparent animal‑welfare and chimaera‑oversight practices.

• FDA leadership stability will accelerate policy signals. Agency priorities will move from temporary pauses to active review lists; industry will respond by accelerating filings in psychedelics, vaccines and tobacco‑product areas.

Bottom line

These reports will push rapid follow‑up work: larger clinical trials of rentosertib, expanded use of xenocortical models for neural disease, and faster regulatory action on high‑profile drug classes. Expect scientific replication attempts, bioethics debate, and renewed investor interest in AI‑discovered therapeutics.

How we got here

Multiple research teams and regulators have published results this month. Small clinical and preclinical studies have reported surprising biology — from an AI‑designed drug altering aging markers to lab-grown human brain tissue integrating in mice — while US officials have moved to stabilise FDA leadership after earlier departures.

Our analysis

The coverage varies in emphasis and tone across publishers. Nature and Stanford reporting, relayed by Ars Technica and Stanford summaries, focus on methods and limitations: Ars Technica described the organoid work as a careful attempt to place human cortical organoids in a more natural context and warned about limitations such as immunocompromise and developmental timing. The New York Post presented the Stanford findings with stronger, simplified language — for example, calling the brain "two organs" and stressing therapeutic promise for ALS and SMA, quoting Kyle Loh saying "Weve shown for the first time...". Those quotes highlight novelty but understate technical caveats that Ars Technica and the original preprints emphasise. On rentosertib, Insilico Medicine and coverage in Fox News, The Japan Times and the New York Post reported that blood proteins shifted and biological age estimates dropped by three to four years. Insilico's founder Alex Zhavoronkov is quoted saying the change is "promising" but preliminary; both Ars summaries and Japan Times reporting note the study's small size (42 patients) and the confounding effect that all subjects had idiopathic pulmonary fibrosis. Bloomberg and AP reporting on FDA appointments quoted department statements naming Michael Davis, Karim Mikhail and Bret Koplow to permanent roles and noted the move was intended to stabilise the agency after earlier controversies. Read the Stanford papers and Insilico's Nature Biotechnology analysis for detailed methods. For regulatory context, read the Department of Health and Human Services announcement and AP or Bloomberg reports that list the named appointees.

Go deeper

• How soon will larger trials of rentosertib begin and who will fund them?
• What ethical rules will govern further human organoid graft experiments in animals?

More on these topics

• United States - Country in North America

  The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.

• New York Post - Newspaper

  The New York Post is a daily newspaper in New York City. The Post also operates NYPost.com, the celebrity gossip site PageSix.com and the entertainment site Decider.com. The modern version of the paper is published in tabloid format.

• Stanford University - Private university in Stanford, California

  Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. Stanford is ranked among the top five universities in the world in major education publications.

• ALS - Neurodegenerative disease characterized by progressive muscular paralysis

  Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND) or Lou Gehrig's disease, is a disease that causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions...

• Marty Makary - Surgeon

  Martin Adel "Marty" Makary is a British-American surgeon, professor, and author. He practices surgical oncology and gastrointestinal laparoscopic surgery at the Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins Sch

• Center for Drug Evaluation and Research - FDA research center

  The Center for Drug Evaluation and Research (CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act. Some biological products are also legally...

• Donald Trump - 45th and 47th U.S. President

  Donald John Trump is an American politician, media personality, and businessman who is the 47th president of the United States. A member of the Republican Party, he served as the 45th president from 2017 to 2021.

• Japan - Country in East Asia

  Japan is an island country of East Asia in the northwest Pacific Ocean. It borders the Sea of Japan to the west and extends from the Sea of Okhotsk in the north to the East China Sea and Taiwan in the south.

• Psilocybin - Chemical compound

  Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolat

• India - Country in South Asia

  India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world.

• Chicken (Gallus gallus domesticus) - Birds

  The chicken is a type of domesticated fowl, a subspecies of the red junglefowl. Chickens are one of the most common and widespread domestic animals, with a total population of 23.7 billion as of 2018. up from more than 19 billion in 2011.

• Nature - Journal

  Nature is a British weekly scientific journal founded and based in London, England. As a multidisciplinary publication, Nature features peer-reviewed research from a variety of academic disciplines, mainly in science and technology.

• United Kingdom - Country in Europe

  The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom or Britain, is a sovereign country located off the north­western coast of the European mainland.

• Center for Tobacco Products - Federal agency

  The Center for Tobacco Products was established by the United States Food and Drug Administration as a result of the Family Smoking Prevention and Tobacco Control Act signed by President Obama in June 2009.

• MDMA - Drug

  3,4-Methyl​enedioxy​methamphetamine, commonly known as ecstasy or molly, is a psychoactive drug primarily used for recreational purposes. The desired effects include altered sensations, increased energy, empathy, as well as pleasure. When taken by mou

• The Japan Times - Newspaper

  The Japan Times is Japan's largest and oldest English-language daily newspaper. It is published by The Japan Times, Ltd., a subsidiary of News2u Holdings, Inc.. It is headquartered in the Kioicho Building in Kioicho, Chiyoda, Tokyo.

• Columbia University - Private university in New York City, New York

  Columbia University is a private Ivy League research university in New York City. Established in 1754 on the grounds of Trinity Church in Manhattan, Columbia is the oldest institution of higher education in New York and the fifth-oldest institution of hig

• Insilico Medicine - Biotechnology company

  Insilico Medicine is a biotechnology company based in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong. The company combines genomics, big data analysis, and deep learning for in silico drug discovery.

• Alex Zhavoronkov - Scientist

  Alex Zhavoronkov (born Aleksandrs Zavoronkovs) is a Latvian-born scientist and author working in biotechnology, regenerative medicine, and aging economics. He is the founder and CEO of Insilico Medicine, and, as of 2024, is the director of the Biogerontol

• Zurich - City in Switzerland

  Zürich is the largest city in Switzerland, and the capital of the canton of Zürich. It is located in north-central Switzerland, at the northwestern tip of Lake Zürich.

• Nature Biotechnology - Peer-reviewed journal

  Nature Biotechnology is a peer reviewed scientific journal published monthly by the Nature Research. The chief editor is Andrew Marshall who is part of an in-house team of editors.